Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings

Por Cooper, David A., Heera, Jayvant, Ive, Prudence, Botes, Mariette, Dejesus, Edwin, Burnside, Robert, Clumeck, Nathan, Walmsley, Sharon, Lazzarin, Adriano, Mukwaya, Geoffrey, Saag, Michael, van Der Ryst, Elna
Publicado em 2014

Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines

Por Capeding, Maria Rosario Z., Gonzales, Maria Liza Antoinette M., Dhingra, Mandeep Singh, D'Cor, Naveena Aloysia, Midde, Venkat Jayanth, Patnaik, Badri Narayan, Thollot, Yaël, Desauziers, Eric
Publicado no Hum Vaccin Immunother (2017)

Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study

Por Aroda, Vanita R., Knowler, William C., Crandall, Jill P., Perreault, Leigh, Edelstein, Sharon L., Jeffries, Susan L., Molitch, Mark E., Pi-Sunyer, Xavier, Darwin, Christine, Heckman-Stoddard, Brandy M., Temprosa, Marinella, Kahn, Steven E., Nathan, David M.
Publicado no Diabetologia (2017)

Magnetic Resonance–Guided Focused Ultrasound for Patients With Painful Bone Metastases: Phase III Trial Results

Por Hurwitz, Mark D., Ghanouni, Pejman, Kanaev, Sergey V., Iozeffi, Dmitri, Gianfelice, David, Fennessy, Fiona Mary, Kuten, Abraham, Meyer, Joshua E., LeBlang, Suzanne D., Roberts, Ann, Choi, Junsung, Larner, James M., Napoli, Alessandro, Turkevich, Vladimir G., Inbar, Yael, Tempany, Clare Mary C., Pfeffer, Raphael M.
Publicado em 2014

Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors

Por Feldman, Darren R., Hu, James, Dorff, Tanya B., Lim, Kristina, Patil, Sujata, Woo, Kaitlin M., Carousso, Maryann, Hughes, Amanda, Sheinfeld, Joel, Bains, Manjit, Daneshmand, Siamak, Ketchens, Charlene, Bajorin, Dean F., Bosl, George J., Quinn, David I., Motzer, Robert J.
Publicado no J Clin Oncol (2016)

Phase I/II clinical trial of everolimus combined with gemcitabine/cisplatin for metastatic triple-negative breast cancer

Por Park, In Hae, Kong, Sun-Young, Kwon, Youngmee, Kim, Min Kyeong, Sim, Sung Hoon, Joo, Jungnam, Lee, Keun Seok
Publicado no J Cancer (2018)

ACTR-19. A MULTICENTER PILOT PHASE II STUDY OF CONTINUING TMZ WITH THE ADDITION OF DISULFIRAM AND COPPER FOR REFRACTORY GLIOBLASTOMA

Por Huang, Jiayi, Chaudhary, Rehka, Cohen, Adam, Fink, Karen, Godlust, Samuel, Boockvar, John, Chinnaiyan, Prakash, Marcus, Stephen, Campian, Jian
Publicado no Neuro Oncol (2018)

Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective...

Por van den Bosch, Sven, Dijkema, Tim, Kunze-Busch, Martina C., Terhaard, Chris H. J., Raaijmakers, Cornelis P. J., Doornaert, Patricia A. H., Hoebers, Frank J. P., Vergeer, Marije R., Kreike, Bas, Wijers, Oda B., Oyen, Wim J. G., Kaanders, Johannes H. A. M.
Publicado no BMC Cancer (2017)

Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China

Por Chen, Nan, Qian, Jiaqi, Chen, Jianghua, Yu, Xueqing, Mei, Changlin, Hao, Chuanming, Jiang, Gengru, Lin, Hongli, Zhang, Xinzhou, Zuo, Li, He, Qiang, Fu, Ping, Li, Xuemei, Ni, Dalvin, Hemmerich, Stefan, Liu, Cameron, Szczech, Lynda, Besarab, Anatole, Neff, Thomas B., Peony Yu, Kin-Hung, Valone, Frank H.
Publicado no Nephrol Dial Transplant (2017)

ACTR-27. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE RECURRENT GLIOBLASTOMA

Por O’Brien, Barbara, de Groot, John, Kamiya-Matsuoka, Carlos, Weathers, Shiao-Pei, Bacha, Jeffrey, Brown, Dennis, Steino, Anne, Langlands, John, Schwartz, Richard, Kanekal, Sarath, Lopez, Lorena, Penas-Prado, Marta
Publicado no Neuro Oncol (2018)

2840. Long-term Efficacy, Safety, and Durability of CAB and RPV as Two Drug Oral Maintenance Therapy: LATTE Week 312 Results

Por Margolis, David, Sutton, Kenneth, De Vente, Jerome, LeBlanc, Roger, DeJesus, Edwin, Smith, Graham, Mills, Anthony, Baril, Jean-Guy, St. Clair, Marty, Stancil, Britt, Williams, Peter, Spreen, William
Publicado no Open Forum Infect Dis (2019)

Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)

Por Hattori, Norifumi, Nakayama, Goro, Uehara, Keisuke, Aiba, Toshisada, Ishigure, Kiyoshi, Sakamoto, Eiji, Tojima, Yuichiro, Kanda, Mitsuro, Kobayashi, Daisuke, Tanaka, Chie, Yamada, Suguru, Koike, Masahiko, Fujiwara, Michitaka, Nagino, Masato, Kodera, Yasuhiro
Publicado no Int J Clin Oncol (2019)

Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study.

Por Lukas Kirzinger, Sandra Boy, Jörg Marienhagen, Gerhard Schuierer, Reiner Neu, Michael Ried, Hans-Stefan Hofmann, Karsten Wiebe, Philipp Ströbel, Christoph May, Julia Kleylein-Sohn, Claudia Baierlein, Ulrich Bogdahn, Alexander Marx, Berthold Schalke
Publicado em 2016-01-01

Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study

Por Kirzinger, Lukas, Boy, Sandra, Marienhagen, Jörg, Schuierer, Gerhard, Neu, Reiner, Ried, Michael, Hofmann, Hans-Stefan, Wiebe, Karsten, Ströbel, Philipp, May, Christoph, Kleylein-Sohn, Julia, Baierlein, Claudia, Bogdahn, Ulrich, Marx, Alexander, Schalke, Berthold
Publicado no PLoS One (2016)

Effect of Cardiac Stem Cells in Patients with Ischemic Cardiomyopathy: Initial Results of the SCIPIO Trial

Por Bolli, Roberto, Chugh, Atul R., D’Amario, Domenico, Loughran, John H., Stoddard, Marcus F., Ikram, Sohail, Beache, Garth M., Wagner, Stephen G., Leri, Annarosa, Hosoda, Toru, Elmore, Julius B., Goihberg, Polina, Cappetta, Donato, Solankhi, Naresh K., Fahsah, Ibrahim, Rokosh, D. Gregg, Slaughter, Mark S., Kajstura, Jan, Anversa, Piero
Publicado em 2011

Phase II study of α-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer

Por Toyoda, Takahide, Kamata, Toshiko, Tanaka, Kazuhisa, Ihara, Fumie, Takami, Mariko, Suzuki, Hidemi, Nakajima, Takahiro, Ikeuchi, Takayuki, Kawasaki, Yohei, Hanaoka, Hideki, Nakayama, Toshinori, Yoshino, Ichiro, Motohashi, Shinichiro
Publicado no J Immunother Cancer (2020)

Targeting Mutant BRAF with Vemurafenib in Relapsed or Refractory Hairy Cell Leukemia

Por Tiacci, Enrico, Park, Jae H., De Carolis, Luca, Chung, Stephen S., Broccoli, Alessandro, Scott, Sasinya, Zaja, Francesco, Devlin, Sean, Pulsoni, Alessandro, Chung, Young Rock, Cimminiello, Michele, Kim, Eunhee, Rossi, Davide, Stone, Richard M., Motta, Giovanna, Saven, Alan, Varettoni, Marzia, Altman, Jessica K., Anastasia, Antonella, Grever, Michael R., Ambrosetti, Achille, Rai, Kanti R., Fraticelli, Vincenzo, Lacouture, Mario E., Carella, Angelo Michele, Levine, Ross L., Leoni, Pietro, Rambaldi, Alessandro, Falzetti, Franca, Ascani, Stefano, Capponi, Monia, Martelli, Maria Paola, Park, Christopher Y., Pileri, Stefano Aldo, Rosen, Neal, Foà, Robin, Berger, Michael F., Zinzani, Pier Luigi, Abdel-Wahab, Omar, Falini, Brunangelo, Tallman, Martin S.
Publicado no N Engl J Med (2015)

Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol

Por Uhl, Matthias, Edler, Lutz, Jensen, Alexandra D, Habl, Gregor, Oelmann, Jan, Röder, Falk, Jäckel, Oliver, Debus, Jürgen, Herfarth, Klaus
Publicado em 2014

Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7)

Por Efremenko, Yuri V, Butov, Dmytro A, Prihoda, Natalia D, Zaitzeva, Svetlana I, Yurchenko, Larisa V, Sokolenko, Nina I, Butova, Tetyana S, Stepanenko, Anna L, Kutsyna, Galyna A, Jirathitikal, Vichai, Bourinbaiar, Aldar S
Publicado em 2013

Phase II Study of Rabbit Anti-Thymocyte Globulin, Cyclosporine, and Granulocyte Colony Stimulating...

Por Garg, Ravin, Faderl, Stefan, Garcia-Manero, Guillermo, Cortes, Jorge, Koller, Charles, Huang, Xuelin, York, Sergerne, Pierce, Sherry, Brandt, Mark, Beran, Miloslav, Borthakur, Gautam, Kantarjian, Hagop, Ravandi, Farhad
Publicado em 2009